Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.
We've made it easier for you to connect! Fill out your NEW profile.

Treatment After CDK4/6 Inhibitors

moderators
moderators Posts: 9,076
edited December 2023 in Targeted Therapy - Before, During, and After
Graff_TreatmentAfterCDK46Inhibitors_2466x1644.png

Treatment After CDK4/6 Inhibitors

Dec 5, 2023

Medical oncologist Stephanie Graff explains the treatment options available after a CDK4/6 inhibitor stops working.

CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer. 

The CDK4/6 inhibitors are:

At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.

Listen to the podcast to hear Dr. Graff explain:

  • how the oral SERD, Orserdu (chemical name: elacestrant), might be used
  • how PARP inhibitors, such as Lynparza (chemical name: olaparib) or Talzenna (chemical name: talazoparib) might be used
  • why using a CDK4/6 inhibitor after another CDK4/6 inhibitor probably won’t be used

Listen now or read the transcript.

Tagged:

Categories

Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.